Caspase-8 represents an important upstream caspase, initiating the apoptosis process downstream of death receptors such as FAS or tumor necrosis factor (TNF). 7 A newly discovered function of caspase-8 is the suppression of RIP3-dependent necroptosis through cleavage of RIP3 and CYLD. 1, 4, 8 Consequently, efficient deletion of caspase-8 sensitizes cells to necroptosis through up-regulation of RIP3 expression. This was shown in many different experimental settings and was the case in our studies in which we used a well-established caspase-8 floxed line 9 and the alfp-cre line mediating robust and efficient deletion of floxed genes in parenchymal livers.
3 Efficient caspase-8-deletion triggered spontaneous RIP3 overexpression (as seen previously in many other organs such as gut or skin 10 ), mild liver injury, and inflammation without any stimulation. 11 Upon MCD diet feeding, caspase-8-deficient mice developed massive RIP3 elevation in hepatocytes and consequently strong liver injury and fibrosis, 3 providing evidence that necroptosis is the main cell death pathway in MCD-diet-induced NASH.
The other important study on caspase-8 in the MCD model cited by the authors used the albumin-cre line for deletion of Caspase-8, 6 which did not lead to overexpression of RIP3. 3 Therefore, and for the fact that RIP3 knockout mice were not used, the study by Hatting et al 6 is not suitable to speculate on the role of necroptosis in the MCD model. The authors of the present review article mention that they have preliminary results on a protective role of caspase-8 in a nutritional model of hepatic steatosis (not MCD diet). 2 However, in our work, caspase-8 deletion did not have any effect in a purely nutritional NAFLD model in mice (data not shown). A careful comparison of methodological differences might bring further light into the controversial function of caspase-8 in different NASH models.
Finally, in our study, we had first shown stainings for RIP3 in liver samples of NASH patients, exhibiting a typical granular staining pattern in hepatocytes surrounding areas of high lipid storage. 3 Of note, Western blot analysis and stainings for RIP3 showed a much clearer result than experiments assessing the levels of the cleaved form of the executioner caspase-3 in human NASH livers, 3 suggesting that necroptosis might be at least equally abundant in human NASH as apoptosis. It should be noted that RIP3 overexpression cannot be taken as equal with execution of necroptosis. However, we can now demonstrate that the phosphorylated form of the protein mixed-lineage-like kinase (p-MLKL), which is considered to be the executional kinase of necroptosis, 12 can be detected in human NASH livers ( Figure 1 ) and that it strikingly resembles the granular staining patterns of RIP3 in NASH patients.
Reply: We appreciate the interest and thoughtful comments of Dr Luedde and colleagues on our review, "Death Receptor-Mediated Cell Death and Proinflammatory Signaling in Nonalcoholic Steatohepatitis." 1 As they have made several seminal insights regarding liver pathobiology, we are flattered that our perspectives on nonalcoholic steatohepatitis (NASH), particularly on necroptosis in NASH, triggered their interest. We are happy to continue a friendly scientific dialogue.
They noted, the ideal model of NASH is a matter of intense discussion. We highlight that animals on methionine-choline-deficient (MCD) diet lose weight and lack insulin resistance, which is in direct contrast to humans with NASH. From our perspective, the MCD diet model is not informative regarding the mechanisms of steatohepatitis occurring in the context of the metabolic syndrome, and the use of this model should be discouraged.
It is well established that cell death by necroptosis requires that caspase 8 activity be inhibited or disrupted. This requirement may challenge the biological relevance of necroptosis in human liver disease. Currently, only a few conditions are known that lead to disrupted caspase 8 function in humans. 2 For instance, a caspase 8 deficiency state (CEDS), caused by a loss-of-function mutation in the caspase 8 gene, is a very rare genetic disorder of the immune system with no liver phenotype. 3, 4 Several viruses and intracellular bacteria may express proteins interfering with caspase 8 activation and can sensitize cells to necroptosis. 5 However, this is not a feature of common hepatotropic viruses such as hepatitis C or B viruses. To date, loss of caspase 8 in steatohepatitis has not been reported. Finally, in preclinical studies of NASH, pharmacologic inhibition of caspases have been associated with beneficial effects, including reduced hepatocyte cell death. [6] [7] [8] As Dr Luedde and colleagues point out, caspase 8 deletion in intestinal or skin epithelium causes receptorinteracting serine/threonine-protein kinase 3 (RIP3)-dependent injury in mice. Similarly, necroptosis may occur Figure 1 . NASH-induced liver injury is decreased in hepatocyte-specific caspase 8 knockout mice (caspase 8 Dhepa ). Wild-type mice and mice carrying a hepatocytespecific deletion of caspase 8 were fed the FFC diet (a NASH-inducing diet high in saturated fats, fructose, and cholesterol) for 3 months, and serum alanine transaminase activity was measured. P value was calculated using unpaired two-tailed t test.
